Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy

BACKGROUND: The exclusion of pregnant women from initial COVID-19 messenger RNA vaccine trials raised hesitancy regarding the benefits of vaccination for pregnant women, hence little is known about vaccines’ efficacy in this population. OBJECTIVE: To determine the maternal-neonatal transplacental tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nir, Omer, Schwartz, Anat, Toussia-Cohen, Shlomi, Leibovitch, Leah, Strauss, Tzipi, Asraf, Keren, Doolman, Ram, Sharabi, Sivan, Cohen, Carmit, Lustig, Yaniv, Regev-Yochay, Gili, Yinon, Yoav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451978/
https://www.ncbi.nlm.nih.gov/pubmed/34547533
http://dx.doi.org/10.1016/j.ajogmf.2021.100492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451978/
https://www.ncbi.nlm.nih.gov/pubmed/34547533
http://dx.doi.org/10.1016/j.ajogmf.2021.100492

Ejemplares similares